Active Ingredient Letermovir
Active Ingredient Details
What is the usage for Letermovir?
This medication is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received a bone marrow transplant. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Letermovir is an anti-viral drug. It works by stopping the growth of the virus.
How many products in the NDC database contain Letermovir?
The NDC database has 10 products with the active ingredient Letermovir. The following table lists all the products that have this active ingredient.
NDC Products with Letermovir
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0006-3075 | Proprietary Name: Prevymis | Letermovir | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
| 0006-3076 | Proprietary Name: Prevymis | Letermovir | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
| 0006-5003 | Proprietary Name: Prevymis | Letermovir | Injection, Solution | Intravenous | Merck Sharp & Dohme Llc | ACTIVE | |
| 0006-5004 | Proprietary Name: Prevymis | Letermovir | Injection, Solution | Intravenous | Merck Sharp & Dohme Llc | ACTIVE | |
| 0006-5085 | Proprietary Name: Prevymis | Letermovir | Pellet | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
| 0006-5086 | Proprietary Name: Prevymis | Letermovir | Pellet | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
| 50473-0126 | Proprietary Name: | Letermovir | Tablet, Film Coated | Msd International Gmbh | ACTIVE | ||
| 50473-0127 | Proprietary Name: | Letermovir | Tablet, Film Coated | Msd International Gmbh | ACTIVE | ||
| 69497-0128 | Proprietary Name: | Letermovir | Injection, Solution | Msd Ireland (carlow) | ACTIVE | ||
| 69766-119 | Proprietary Name: | Letermovir | Powder | Msn Life Sciences Private Limited | ACTIVE |
